![]() |
Trials |
Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination with Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects with Solid Malignancies and Deregulated FGF Pathway SignalingCancer type: Lung cancer Phase: I Principal Investigator: Lassen Ulrik Country: DK Keywords: Denmark, Rigshospitalet, Squamous NSCLC, FGFR1 Status: Completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01918254?term=BP28752&rank=1 |